Connectyx Announces Grant of License from National Institutes of Health for Use of Novel Monoclonal Antibody to Treat Glioblastoma
I just copied and pasted the title of the article. It seems to speak for itself.. Why wouldn't they exercise their right (option) to commercialize this? That's the whole point of this pursuit.
Market Data 
Markets 
AI
